Lu Y S, Pakes S P, Massey L
Department of Pathology, University of Texas Health Science Center at Dallas 75235.
J Clin Microbiol. 1987 Nov;25(11):2173-80. doi: 10.1128/jcm.25.11.2173-2180.1987.
Hyperimmune rabbit sera directed to the KSCN extract of 3:A Pasteurella multocida were characterized by enzyme-linked immunosorbent assay (ELISA), presolubilized cell radioimmunoprecipitation, and immunoblotting analysis. The results showed that the hyperimmune serum had a very high titer of immunoglobulin G ELISA antibody and a negligible immunoglobulin A ELISA antibody, precipitated 10 different outer membrane protein antigens by radioimmunoprecipitation, and reacted to 10 different membrane vesicle antigens of P. multocida by immunoblotting analysis. The hyperimmune rabbit sera were also evaluated for protective efficacy against experimental rabbit pasteurellosis by homologous challenge. Thirty-six rabbits were divided into four groups. Group 1, 2, and 3 rabbits were inoculated intranasally with hyperimmune rabbit serum, phosphate-buffered saline, or normal rabbit serum, respectively, at 24 h prior to and 24, 48, and 72 h after intranasal challenge with the virulent homologous P. multocida strain. Group 4 rabbits were inoculated with normal rabbit serum without challenge. Necropsies of surviving rabbits were performed 2 weeks postinfection. The mortality rates for groups 1 through 4 were 25% (3 of 12), 67% (8 of 12), 75% (6 of 8), and 0% (0 of 4), respectively. The prevalence and severity of pneumonia were significantly lower in the hyperimmune serum-treated rabbits. The prevalence of P. multocida colonization in lungs was significantly lower in group 1 rabbits, and the geometric mean CFU of P. multocida in lungs was 59,166-fold less in group 1 rabbits than in group 3 rabbits. The geometric mean CFU of P. multocida in nasal cavities of group 1 rabbits was significantly lower than that of group 3 rabbits. All challenged rabbits (groups 1,2, and 3) had elevated nasal immunoglobulin A and pulmonary (lung lavage) immunoglobulin A antibody levels at necropsy (day 14 postinfection). Similarly, all challenged rabbits had elevated levels of ELISA immunoglobulin G antibody in serum at day 14 but not at day 7 postinfection, indicating that rabbits receiving hyperimmune serum can mount a specific humoral immune response against the homologous challenge P. multocida organisms. We concluded that hyperimmune serum directed to the KSCN extract of 3:A P. multocida provides significant protection against homologous challenge in rabbits.
用酶联免疫吸附测定(ELISA)、预溶解细胞放射免疫沉淀和免疫印迹分析对针对多杀性巴氏杆菌3:A型KSCN提取物的超免疫兔血清进行了表征。结果表明,超免疫血清具有非常高滴度的免疫球蛋白G ELISA抗体和可忽略不计的免疫球蛋白A ELISA抗体,通过放射免疫沉淀沉淀出10种不同的外膜蛋白抗原,并通过免疫印迹分析与多杀性巴氏杆菌的10种不同膜泡抗原发生反应。还通过同源攻击评估了超免疫兔血清对实验性兔巴氏杆菌病的保护效果。将36只兔子分为四组。第1、2和3组兔子分别在经强毒同源多杀性巴氏杆菌菌株鼻内攻击前24小时以及攻击后24、48和72小时鼻内接种超免疫兔血清、磷酸盐缓冲盐水或正常兔血清。第4组兔子接种正常兔血清且不进行攻击。在感染后2周对存活兔子进行尸检。第1至4组的死亡率分别为25%(12只中的3只)、67%(12只中的8只)、75%(8只中的6只)和0%(4只中的0只)。超免疫血清处理的兔子中肺炎的发生率和严重程度显著较低。第1组兔子肺部多杀性巴氏杆菌定植的发生率显著较低,且第1组兔子肺部多杀性巴氏杆菌的几何平均菌落形成单位比第3组兔子少59166倍。第1组兔子鼻腔中多杀性巴氏杆菌的几何平均菌落形成单位显著低于第3组兔子。所有受攻击的兔子(第1、2和3组)在尸检时(感染后第14天)鼻内免疫球蛋白A和肺部(肺灌洗)免疫球蛋白A抗体水平升高。同样,所有受攻击的兔子在感染后第14天血清中的ELISA免疫球蛋白G抗体水平升高,但在第7天未升高,这表明接受超免疫血清的兔子能够针对同源攻击的多杀性巴氏杆菌生物体产生特异性体液免疫反应。我们得出结论,针对多杀性巴氏杆菌3:A型KSCN提取物的超免疫血清在兔子中对同源攻击提供了显著保护。